De Marzo AM - Search Results

1

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J. Antonarakis ES, et al. Among authors: de marzo am. N Engl J Med. 2014 Sep 11;371(11):1028-38. doi: 10.1056/NEJMoa1315815. Epub 2014 Sep 3. N Engl J Med. 2014. PMID: 25184630 Free PMC article.

2

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Zhong H, et al. Among authors: de marzo am. Cancer Res. 1999 Nov 15;59(22):5830-5. Cancer Res. 1999. PMID: 10582706

3

GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.

Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S, Nelson WG. Tchou JC, et al. Among authors: de marzo am. Int J Oncol. 2000 Apr;16(4):663-76. doi: 10.3892/ijo.16.4.663. Int J Oncol. 2000. PMID: 10717233

4

Rational basis for Trk inhibition therapy for prostate cancer.

Weeraratna AT, Arnold JT, George DJ, DeMarzo A, Isaacs JT. Weeraratna AT, et al. Prostate. 2000 Oct 1;45(2):140-8. doi: 10.1002/1097-0045(20001001)45:2<140::aid-pros8>3.0.co;2-#. Prostate. 2000. PMID: 11027413

5

Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.

Nelson CP, Kidd LC, Sauvageot J, Isaacs WB, De Marzo AM, Groopman JD, Nelson WG, Kensler TW. Nelson CP, et al. Among authors: de marzo am. Cancer Res. 2001 Jan 1;61(1):103-9. Cancer Res. 2001. PMID: 11196146

6

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

DeWeese TL, van der Poel H, Li S, Mikhak B, Drew R, Goemann M, Hamper U, DeJong R, Detorie N, Rodriguez R, Haulk T, DeMarzo AM, Piantadosi S, Yu DC, Chen Y, Henderson DR, Carducci MA, Nelson WG, Simons JW. DeWeese TL, et al. Cancer Res. 2001 Oct 15;61(20):7464-72. Cancer Res. 2001. PMID: 11606381 Clinical Trial.

7

GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.

Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, DeWeese TL, De Marzo AM, Nelson WG. Lin X, et al. Among authors: de marzo am. Am J Pathol. 2001 Nov;159(5):1815-26. doi: 10.1016/S0002-9440(10)63028-3. Am J Pathol. 2001. PMID: 11696442 Free PMC article.

8

Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.

Zha S, Gage WR, Sauvageot J, Saria EA, Putzi MJ, Ewing CM, Faith DA, Nelson WG, De Marzo AM, Isaacs WB. Zha S, et al. Among authors: de marzo am. Cancer Res. 2001 Dec 15;61(24):8617-23. Cancer Res. 2001. PMID: 11751373

9

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM. Luo J, et al. Among authors: de marzo am. Cancer Res. 2002 Apr 15;62(8):2220-6. Cancer Res. 2002. PMID: 11956072

10

Focus on prostate cancer.

Isaacs W, De Marzo A, Nelson WG. Isaacs W, et al. Cancer Cell. 2002 Aug;2(2):113-6. doi: 10.1016/s1535-6108(02)00103-4. Cancer Cell. 2002. PMID: 12204531 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page